Product Description
Cytokeratin 13 polyclonal Antibody | BS90375 | Bioworld
Host: Rabbit
Reactivity: Human, Mouse, zebrafish
Application: WB ICC IHC
Application Range: WB:1:1,000-1:5,000 ICC:1:50-1:200 IHC:1:50-1:200
Background: Cytokeratins comprise a diverse group of intermediate filament proteins (IFPs) that are expressed as pairs in both keratinized and non-keratinized epithelial tissue. Cytokeratins play a critical role in differentiation and tissue specialization and function to maintain the overall structural integrity of epithelial cells. Cytokeratins have been found to be useful markers of tissue differentiation, which is directly applicable to the characterization of malignant tumors. Cytokeratins 10 and 13 are present in the cytoskeletal region of a subset of squamous cell carcinomas. Cytokeratin 13 belongs to the intermediate filament family and is a heterotetramer of two type I acidic and two type II basic keratins. It is generally associated with cytokeratin 4. Defects in the KRT13 gene are a cause of white sponge nevus of cannon (WSN), a rare autosomal dominant disorder which predominantly affects noncornified stratified squamous epithelia and is characterized by the presence of soft, white and spongy plaques in the oral mucosa.
Storage & Stability: Store at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Specificity: Cytokeratin 13 polyclonal Antibody detects endogenous levels of Cytokeratin 13 protein.
Molecular Weight: 50 kDa
Note: For research use only, not for use in diagnostic procedure.
Alternative Names: CK-13, K13, KRT13, 47 kDa cytokeratin, CK-13, CK13, Cytokeratin 13, Cytokeratin-13, K13, K1C13, Ka13, Keratin 13, Keratin, keratin type I cytoskeletal 13, Keratin-13, Krt-1.13, Krt1-13, KRT13, MGC161462, MGC3781, type I cytoskeletal 13, Type I keratin Ka13, WSN2,
Immunogen: recombinant protein
Conjugate: Unconjugated
Modification: Unmodification
Purification & Purity: ProA affinity purified
Pathway: